Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours (original) (raw)

Abstract

Polyclonal antibodies have been raised in rabbits to a haemocyanin adduct of a reductively-activated, fluorinated analogue of misonidazole. Fluorescence immunohistochemical studies show that the polyclonal antibodies bind to spheroid sections and tumour sections in patterns similar to those revealed by autoradiographic studies with a tritium-labelled derivative of the fluorinated misonidazole analogue.

395

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chapman J. D., Baer K., Lee J. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res. 1983 Apr;43(4):1523–1528. [PubMed] [Google Scholar]
  2. Chapman J. D., Franko A. J., Sharplin J. A marker for hypoxic cells in tumours with potential clinical applicability. Br J Cancer. 1981 Apr;43(4):546–550. doi: 10.1038/bjc.1981.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chapman J. D. The detection and measurement of hypoxic cells in solid tumors. Cancer. 1984 Dec 1;54(11):2441–2449. doi: 10.1002/1097-0142(19841201)54:11<2441::aid-cncr2820541122>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  4. Clement J. J., Tanaka N., Song C. W. Tumor reoxygenation and postirradiation vascular changes. Radiology. 1978 Jun;127(3):799–803. doi: 10.1148/127.3.799. [DOI] [PubMed] [Google Scholar]
  5. Franko A. J., Chapman J. D., Koch C. J. Binding of misonidazole to EMt6 and V79 spheroids. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):737–739. doi: 10.1016/0360-3016(82)90724-6. [DOI] [PubMed] [Google Scholar]
  6. Franko A. J., Freedman H. I., Koch C. J. Oxygen supply to spheroids in spinner and liquid-overlay culture. Recent Results Cancer Res. 1984;95:162–167. doi: 10.1007/978-3-642-82340-4_10. [DOI] [PubMed] [Google Scholar]
  7. Franko A. J. Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids. Radiat Res. 1985 Jul;103(1):89–97. [PubMed] [Google Scholar]
  8. Franko A. J., Koch C. J. Binding of misonidazole to V79 spheroids and fragments of Dunning rat prostatic and human colon carcinomas in vitro: diffusion of oxygen and reactive metabolites. Int J Radiat Oncol Biol Phys. 1984 Aug;10(8):1333–1336. doi: 10.1016/0360-3016(84)90343-2. [DOI] [PubMed] [Google Scholar]
  9. Franko A. J., Koch C. J. The radiation response of hypoxic cells in EMT6 spheroids in suspension culture does model data from EMT6 tumors. Radiat Res. 1983 Dec;96(3):497–504. [PubMed] [Google Scholar]
  10. Franko A. J. Misonidazole and other hypoxia markers: metabolism and applications. Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1195–1202. doi: 10.1016/0360-3016(86)90257-9. [DOI] [PubMed] [Google Scholar]
  11. Fuciarelli A. F., Miller G. G., Raleigh J. A. An immunochemical probe for 8,5'-cycloadenosine-5'-monophosphate and its deoxy analog in irradiated nucleic acids. Radiat Res. 1985 Dec;104(3):272–283. [PubMed] [Google Scholar]
  12. Garrecht B. M., Chapman J. D. The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole. Br J Radiol. 1983 Oct;56(670):745–753. doi: 10.1259/0007-1285-56-670-745. [DOI] [PubMed] [Google Scholar]
  13. Hirst D. G., Hazlehurst J. L., Brown J. M. Changes in misonidazole binding with hypoxic fraction in mouse tumors. Int J Radiat Oncol Biol Phys. 1985 Jul;11(7):1349–1355. doi: 10.1016/0360-3016(85)90251-2. [DOI] [PubMed] [Google Scholar]
  14. Jette D. C., Wiebe L. I., Chapman J. D. Synthesis and in vivo studies of the radiosensitizer 4-[82Br]bromomisonidazole. Int J Nucl Med Biol. 1983;10(4):205–210. doi: 10.1016/0047-0740(83)90080-3. [DOI] [PubMed] [Google Scholar]
  15. Kennedy K. A., Teicher B. A., Rockwell S., Sartorelli A. C. The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochem Pharmacol. 1980 Jan 1;29(1):1–8. doi: 10.1016/0006-2952(80)90235-x. [DOI] [PubMed] [Google Scholar]
  16. McCalla D. R., Reuvers A., Kaiser C. Mode of action of nitrofurazone. J Bacteriol. 1970 Dec;104(3):1126–1134. doi: 10.1128/jb.104.3.1126-1134.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McClelland R. A., Fuller J. R., Seaman N. E., Rauth A. M., Battistella R. 2-Hydroxylaminoimidazoles--unstable intermediates in the reduction of 2-nitroimidazoles. Biochem Pharmacol. 1984 Jan 15;33(2):303–309. doi: 10.1016/0006-2952(84)90489-1. [DOI] [PubMed] [Google Scholar]
  18. Miller G. G., Ngan-Lee J., Chapman J. D. Intracellular localization of radioactively labeled misonidazole in EMT-6-tumor cells in vitro. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):741–744. doi: 10.1016/0360-3016(82)90725-8. [DOI] [PubMed] [Google Scholar]
  19. Raleigh J. A., Franko A. J., Koch C. J., Born J. L. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label. Br J Cancer. 1985 Feb;51(2):229–235. doi: 10.1038/bjc.1985.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Raleigh J. A., Franko A. J., Treiber E. O., Lunt J. A., Allen P. S. Covalent binding of a fluorinated 2-nitroimidazole to EMT-6 tumors in Balb/C mice: detection by F-19 nuclear magnetic resonance at 2.35 T. Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1243–1245. doi: 10.1016/0360-3016(86)90268-3. [DOI] [PubMed] [Google Scholar]
  21. Raleigh J. A., Liu S. F. Reductive fragmentation of 2-nitroimidazoles: amines and aldehydes. Int J Radiat Oncol Biol Phys. 1984 Aug;10(8):1337–1340. doi: 10.1016/0360-3016(84)90344-4. [DOI] [PubMed] [Google Scholar]
  22. Rasey J. S., Grunbaum Z., Krohn K., Nelson N., Chin L. Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids. Radiat Res. 1985 Mar;101(3):473–479. [PubMed] [Google Scholar]
  23. Rasey J. S., Krohn K. A., Grunbaum Z., Conroy P. J., Bauer K., Sutherland R. M. Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cells. Radiat Res. 1985 Apr;102(1):76–85. [PubMed] [Google Scholar]
  24. Silver A. R., McNeil S. S., O'Neill P., Jenkins T. C., Ahmed I. Induction of DNA strand breaks by reduced nitroimidazoles. Implications for DNA base damage. Biochem Pharmacol. 1986 Nov 15;35(22):3923–3928. doi: 10.1016/0006-2952(86)90005-5. [DOI] [PubMed] [Google Scholar]
  25. Smith B. R., Born J. L. Metabolism and excretion of [3H]misonidazole by hypoxic rat liver. Int J Radiat Oncol Biol Phys. 1984 Aug;10(8):1365–1370. doi: 10.1016/0360-3016(84)90350-x. [DOI] [PubMed] [Google Scholar]
  26. Smith B. R. Hypoxia-enhanced reduction and covalent binding of [2-3H]misonidazole in the perfused rat liver. Biochem Pharmacol. 1984 Apr 15;33(8):1379–1381. doi: 10.1016/0006-2952(84)90199-0. [DOI] [PubMed] [Google Scholar]
  27. Urtasun R. C., Chapman J. D., Raleigh J. A., Franko A. J., Koch C. J. Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia. Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1263–1267. doi: 10.1016/0360-3016(86)90273-7. [DOI] [PubMed] [Google Scholar]
  28. Urtasun R. C., Koch C. J., Franko A. J., Raleigh J. A., Chapman J. D. A novel technique for measuring human tissue pO2 at the cellular level. Br J Cancer. 1986 Sep;54(3):453–457. doi: 10.1038/bjc.1986.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Varghese A. J. Glutathione conjugates of misonidazole. Biochem Biophys Res Commun. 1983 May 16;112(3):1013–1020. doi: 10.1016/0006-291x(83)91719-9. [DOI] [PubMed] [Google Scholar]
  30. Varghese A. J., Gulyas S., Mohindra J. K. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo. Cancer Res. 1976 Oct;36(10):3761–3765. [PubMed] [Google Scholar]
  31. Wiebe L. I., Jette D. C., Chapman J. D. Electron-affinic compounds for labelling hypoxic cells: the synthesis and characterization of 1-[2-(2-iodophenoxy)-ethyl]-2-nitroimidazole. Nuklearmedizin. 1984 Apr;23(2):63–67. [PubMed] [Google Scholar]